Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Fluoxetine
Drug ID BADD_D00932
Description Fluoxetine is a 2nd generation antidepressant categorized as a selective serotonin reuptake inhibitor (SSRI).[A181673] It gained FDA approval in 1987 and although it was initially intended for the treatment of depression, today it is commonly prescribed to manage depression in addition to various other pathologies.[L7721]
Indications and Usage Fluoxetine is indicated for both acute and maintenance treatment of major depressive disorder, obsessive compulsive disorder, and bulimia nervosa; however, it is only indicated for acute treatment of panic disorder independent of whether agoraphobia is present.[L7664] Fluoxetine may also be used in combination with olanzapine to treat depression related to Bipolar I Disorder, and treatment resistant depression.[L7664]
Marketing Status approved; vet_approved
ATC Code N06AB03
DrugBank ID DB00472
KEGG ID D00326
MeSH ID D005473
PubChem ID 3386
TTD Drug ID D0TR5X
NDC Product Code 0093-0807; 43063-839; 53002-2305; 61919-869; 62332-243; 71335-0924; 0615-8093; 0093-7198; 50090-3180; 50111-647; 50228-421; 59651-308; 68645-130; 0615-7625; 72241-009; 0904-5785; 0904-7195; 49884-468; 55111-150; 59651-324; 62332-242; 65862-306; 71209-041; 61919-885; 63304-632; 72241-008; 80426-044; 63187-233; 63629-8179; 70518-3752; 71335-0565; 80425-0313; 59651-309; 13668-443; 46708-273; 68645-131; 80426-045; 23155-028; 23155-030; 42291-398; 42571-388; 62332-024; 63187-089; 71335-1048; 0904-5784; 23155-029; 42291-396; 42571-389; 62332-022; 72162-1506; 72241-007; 16714-112; 16714-113; 42291-397; 42571-387; 43598-566; 46708-272; 50228-420; 58118-0645; 70518-1619; 71209-042; 13668-473; 50111-648; 55154-1341; 61919-100; 62332-023; 63629-2201; 71205-178; 71205-188; 71209-040; 42708-025; 46708-271; 53002-5016
UNII 01K63SUP8D
Synonyms Fluoxetine | Fluoxetin | N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine | Lilly-110140 | Lilly 110140 | Lilly110140 | Sarafem | Fluoxetine Hydrochloride | Prozac
Chemical Information
Molecular Formula C17H18F3NO
CAS Registry Number 54910-89-3
SMILES CNCCC(C1=CC=CC=C1)OC2=CC=C(C=C2)C(F)(F)F
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Bradyphrenia17.03.03.004; 19.10.03.0020.000049%-
Abulia17.02.05.040; 19.01.02.0090.000020%-
Sudden onset of sleep17.15.04.0030.000020%-
Cervix haemorrhage uterine21.06.01.005; 24.07.03.011---
Urogenital haemorrhage20.08.01.006; 21.10.05.008; 24.07.01.044---
Neonatal hypoxia18.04.15.002; 22.11.02.0020.000059%-
Morbid thoughts19.10.03.0040.000020%-
Ventricular hypokinesia02.04.02.0130.000020%-
Lupus-like syndrome10.04.03.003; 15.06.02.004; 23.03.02.0040.000020%-
Cardiopulmonary failure02.05.01.004; 22.02.06.0040.000030%-
Self-injurious ideation19.12.01.0070.000201%-
Madarosis06.06.04.010; 23.02.02.0040.000039%-
Facial paresis17.04.03.0020.000069%
Acute coronary syndrome02.02.02.015; 24.04.04.011---
Necrotising colitis07.08.01.0130.000020%-
Metabolic syndrome05.06.02.007; 14.06.02.007; 24.08.02.0140.000020%-
Large intestinal haemorrhage07.12.03.003; 24.07.02.026--
Drug tolerance08.06.01.003---
Eosinophilic pneumonia acute01.02.04.004; 22.01.01.0080.000039%-
Musculoskeletal stiffness15.03.05.0270.000181%-
Musculoskeletal discomfort15.03.04.001---
Inappropriate antidiuretic hormone secretion05.03.03.001; 14.05.07.0010.000148%-
Clonic convulsion17.12.03.008---
Secretion discharge08.01.03.0190.000083%-
Growth retardation05.03.02.007; 14.03.02.031; 15.03.05.0160.000020%
Cerebral haematoma17.08.01.014; 24.07.04.0060.000020%-
Depressive symptom19.15.02.0030.000020%-
Affect lability19.04.01.0010.000112%-
Cerebral disorder17.02.10.0170.000049%-
Phonophobia04.03.01.008; 19.06.03.0030.000020%-
The 26th Page    First    Pre   26 27 28 29 30    Next   Last    Total 35 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene